Arthritis can limit daily activities, but the Aging Untold experts say there are effective ways to manage symptoms and ...

Millions of people living with arthritis may unknowingly be eating foods that increase inflammation, joint stiffness, and ...

This measure of how well controlled your psoriatic arthritis is can be used to guide treatment decisions.

BMS has secured approval from the European Commission for Sotyktu (deucravacitinib) to treat active psoriatic arthritis (PsA).

European Commission approves Bristol Myers Squibb’s Sotyktu for the treatment of active psoriatic arthritis in adults: Princeton, New Jersey Monday, May 11, 2026, 15:00 Hrs [IST ...

In the pivotal Phase 3 POETYK PsA clinical trials, Sotyktu demonstrated superiority compared with placebo at Week 16 across multiple endpoints, including skin and joint symptoms, with improvements in ...

A comparative analysis identifies the top IL-23 inhibitors that were least likely to be associated with the development of ...

Background Patients with psoriasis (PsO) are at increased risk of developing psoriatic arthritis (PsA). Emerging evidence ...

As COVID-19 cases continue to rise across the United States, scientists are monitoring the spread of a new variant called LB.1. The highly contagious omicron subvariant, along with the fast-growing ...

A 27-year-old woman from Colchester living with psoriatic arthritis has become the face of a national campaign to raise ...

Psoriatic arthritis (PsA) is often misunderstood, and those misconceptions can make it harder for people to recognize symptoms, seek care, or understand what living with the condition is really like.

Share on Pinterest Could the body’s own GLP-1 hormones hold the key to treating arthritis? Gabriel Mello/Getty Images GLP-1 receptor agonists such as Ozempic, Zepbound, or Mounjaro are used to treat ...